Specifically, serous tubal intraepithelial carcinomas (STICs) and morphologically normal cells carrying TP53 mutation were identified as potential tumor precursors in the FT fimbriae of BRCA1/BRCA2 mutation carriers10–12. This evidence concerns the gene TP53 and neoplasm.